Metraipolis › archive › dc_cfa1086fe6c8

Cost-effective analysis of sugemalimab plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1… — Europe PMC PMID:40917418

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40917418
DOI
10.3389/fpubh.2025.1604372
License (as archived)
solo-consultazione
Archived
2026-11-10T10:34:01.504Z
SHA-256 of the archived text
0bb992f6cec8b9a3786e3cb536e49194c7588f59e44a778d8edab5ab46570b11
Stable URL of this page
https://metraipolis.com/documento/dc_cfa1086fe6c8

How to cite

Cost-effective analysis of sugemalimab plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1… — Europe PMC PMID:40917418 — Europe PMC (en), https://europepmc.org/article/MED/40917418 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cfa1086fe6c8 (Metraipolis archive dc_cfa1086fe6c8, sha256 0bb992f6cec8b9a3786e3cb536e49194c7588f59e44a778d8edab5ab46570b11)
BibTeX
@misc{dccfa1086fe6c8,
  title = {Cost-effective analysis of sugemalimab plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1… — Europe PMC PMID:40917418},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40917418},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cfa1086fe6c8; sha256 0bb992f6cec8b9a3786e3cb536e49194c7588f59e44a778d8edab5ab46570b11},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40917418. Agents can read the archived copy with the MCP tool read_document.